Role of E3 Ligase UBR5 in Alternative Splicing during B Cell Development and Activation
Role of E3 Ligase UBR5 in Alternative Splicing during B Cell Development and Activation
批准号:
10669468
负责人:
Shannon Buckley
金额:
$38.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-25 至 2025-07-31
关键词:
Alternative SplicingAntibodiesB-Cell ActivationB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesC-terminalCell CycleCell MaturationCell physiologyCellsComplexCysteineDNA DamageDNA RepairDataDefectDevelopmentDown-RegulationGeneticGenetic TranscriptionGoalsHematopoietic NeoplasmsImmune systemImmunityImmunizationImmunoglobulin Class SwitchingImmunoglobulin DImmunoglobulin Somatic HypermutationImmunoglobulin Switch RecombinationImmunologic Deficiency SyndromesImmunoprecipitationLengthLigaseLymphomagenesisLymphopoiesisMalignant NeoplasmsMantle Cell LymphomaMediatingMessenger RNAMolecularMutant Strains MiceMutateNatural ImmunityPTPRC genePathway interactionsPatientsPhenotypePlasma CellsPlayPopulationProcessProteinsProteomicsRNA SplicingRegulationRoleSignal PathwaySignal TransductionSpleenSpliceosomesStreamStructure of germinal center of lymph nodeTestingTranscriptTranscriptional RegulationTranslationsUbiquitinUp-RegulationV(D)J RecombinationVariantadaptive immunitycell motilityconditional mutantimmune system functionimprovedinsightleukemia/lymphomamutantnoveloverexpressionperipheral bloodplasma cell differentiationprotein expressionscaffoldtooltumorubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Proper B cell development is an essential part of innate and adaptive immunity. Coordination of a
number of molecular mechanisms are required to facilitate B cell development, maturation, activation, and
survival of B cells. Recently, the ubiquitin E3 ligase, UBR5 has been found mutated in a significant number of
cases of patients with mantle cell lymphoma, implicating the E3 ligase in B cell development. UBR5 is a key
regulator of DNA damage repair, transcription, translation, and our data suggests mRNA splicing via the
spliceosome. UBR5 is a HECT domain ligase, which contains a cysteine residue that is responsible for
ubiquitin transfer to its substrates. To elucidate the role of UBR5 in B cell maturation and activation we
generated a conditional mutant disrupting the C-terminal HECT domain. Loss of the HECT domain leads to a
block in maturation of B cells in the spleen with a reduction of B1 and marginal B cell subsets, as well as
phenotypic alterations and functional defects of follicular B cells. Proteomic studies reveal up-regulation of
spliceosome proteins in B cells lacking the HECT domain of UBR5, and that UBR5 interacts with splicing
factors. To further understand the functional role of UBR5 in regulating B cells activation and maturation and
the consequences of aberrant spliceosome component expression, we will define the role of UBR5 during
germinal center formation and activation (Aim 1), determine the ubiquitin independent vs. dependent function
in B cells (Aim2), and identify the role of spliceosome and altered transcripts in B cell activation (Aim 3). These
studies will unravel a novel role of UBR5 in B cell maturation by regulating alternative splicing of key transcripts
during B cell development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of E3 Ligase UBR5 in Alternative Splicing during B Cell Development and Activation
-
批准号:10297399
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2021
-
负责人:Shannon Buckley
-
依托单位:
Dissecting the Role Ubiquitin E3 Ligase UBR5 in Lymphomagenesis
-
批准号:10276282
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2021
-
负责人:Shannon Buckley
-
依托单位:
Dissecting the Role Ubiquitin E3 Ligase UBR5 in Lymphomagenesis
-
批准号:10696146
-
项目类别:
-
资助金额:$40.02万
-
财政年份:2021
-
负责人:Shannon Buckley
-
依托单位:
Dissecting the Role Ubiquitin E3 Ligase UBR5 in Lymphomagenesis
-
批准号:10682906
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2021
-
负责人:Shannon Buckley
-
依托单位:
Role of E3 Ligase, UBR5, in Hematopoietic Differentiation and Lymphomagenesis
-
批准号:10117103
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2018
-
负责人:Shannon Buckley
-
依托单位:
Role of E3 Ligase, UBR5, in Hematopoietic Differentiation and Lymphomagenesis
-
批准号:9920178
-
项目类别:
-
资助金额:$27.91万
-
财政年份:--
-
负责人:Shannon Buckley
-
依托单位:
海外基金